Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

In-Depth Glyco-Peptidomics Approach Reveals Unexpected Diversity of Glycosylated Peptides and Atypical Post-Translational Modifications in Dendroaspis angusticeps Snake Venom.

Degueldre M, Echterbille J, Smargiasso N, Damblon C, Gouin C, Mourier G, Gilles N, De Pauw E, Quinton L.

Int J Mol Sci. 2017 Nov 18;18(11). pii: E2453. doi: 10.3390/ijms18112453.

2.

A New Chimeric Natriuretic Peptide, CNAAC, for the Treatment of Left Ventricular Dysfunction after Myocardial Infarction.

Zhang SM, Zhao HL, Gu XM, Li J, Feng N, Wang YM, Fan R, Chen WS, Pei JM.

Sci Rep. 2017 Aug 30;7(1):10099. doi: 10.1038/s41598-017-10748-6.

3.

Coralsnake Venomics: Analyses of Venom Gland Transcriptomes and Proteomes of Six Brazilian Taxa.

Aird SD, da Silva NJ, Qiu L, Villar-Briones A, Saddi VA, Pires de Campos Telles M, Grau ML, Mikheyev AS.

Toxins (Basel). 2017 Jun 8;9(6). pii: E187. doi: 10.3390/toxins9060187.

4.

Innovative Therapeutics: Designer Natriuretic Peptides.

Meems LMG, Burnett JC Jr.

JACC Basic Transl Sci. 2016 Dec;1(7):557-567. doi: 10.1016/j.jacbts.2016.10.001.

5.

The relaxant effect of the Montivipera bornmuelleri snake venom on vascular contractility.

Accary C, Hraoui-Bloquet S, Sadek R, Alameddine A, Fajloun Z, Desfontis JC, Mallem Y.

J Venom Res. 2016 Feb 23;7:10-15. eCollection 2016.

6.

Lebetin 2, a Snake Venom-Derived Natriuretic Peptide, Attenuates Acute Myocardial Ischemic Injury through the Modulation of Mitochondrial Permeability Transition Pore at the Time of Reperfusion.

Tourki B, Matéo P, Morand J, Elayeb M, Godin-Ribuot D, Marrakchi N, Belaidi E, Messadi E.

PLoS One. 2016 Sep 12;11(9):e0162632. doi: 10.1371/journal.pone.0162632. eCollection 2016.

7.

Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions.

Lee CY, Huntley BK, McCormick DJ, Ichiki T, Sangaralingham SJ, Lisy O, Burnett JC Jr.

Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):98-105. doi: 10.1093/ehjcvp/pvv040. Epub 2015 Dec 10.

8.

Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness.

Li D, Paterson DJ.

J Physiol. 2016 Jul 15;594(14):3993-4008. doi: 10.1113/JP271827. Epub 2016 May 5. Review.

9.

The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.

Volpe M, Carnovali M, Mastromarino V.

Clin Sci (Lond). 2016 Jan;130(2):57-77. doi: 10.1042/CS20150469. Review.

10.

The value of (NT-pro) BNP in the diagnosis, prognosis and treatment of congestive heart failure.

van Kimmenade RR, Bakker JA, Crijns HJ, van Dieijen-Visser MP, Pinto YM.

Neth Heart J. 2004 Feb;12(2):61-63. Review.

11.
12.

Venom down under: dynamic evolution of Australian elapid snake toxins.

Jackson TN, Sunagar K, Undheim EA, Koludarov I, Chan AH, Sanders K, Ali SA, Hendrikx I, Dunstan N, Fry BG.

Toxins (Basel). 2013 Dec 18;5(12):2621-55. doi: 10.3390/toxins5122621.

13.

Physiology and clinical significance of natriuretic hormones.

Chopra S, Cherian D, Verghese PP, Jacob JJ.

Indian J Endocrinol Metab. 2013 Jan;17(1):83-90. doi: 10.4103/2230-8210.107869.

14.

Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure.

von Lueder TG, Sangaralingham SJ, Wang BH, Kompa AR, Atar D, Burnett JC Jr, Krum H.

Circ Heart Fail. 2013 May;6(3):594-605. doi: 10.1161/CIRCHEARTFAILURE.112.000289. Review. No abstract available.

15.

CD-NP: a novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heart.

Martin FL, Sangaralingham SJ, Huntley BK, McKie PM, Ichiki T, Chen HH, Korinek J, Harders GE, Burnett JC Jr.

PLoS One. 2012;7(12):e52422. doi: 10.1371/journal.pone.0052422. Epub 2012 Dec 18.

16.

Dendroaspis natriuretic peptide regulates the cardiac L-type Ca2+ channel activity by the phosphorylation of α1c proteins.

Park SA, Kim TG, Han MK, Ha KC, Kim SZ, Kwak YG.

Exp Mol Med. 2012 Jun 30;44(6):363-8. doi: 10.3858/emm.2012.44.6.041.

17.

Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.

Pandey KN.

Can J Physiol Pharmacol. 2011 Aug;89(8):557-73. doi: 10.1139/y11-054. Epub 2011 Aug 4. Review.

18.

Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation.

Dickey DM, Potter LR.

J Mol Cell Cardiol. 2011 Jul;51(1):67-71. doi: 10.1016/j.yjmcc.2011.03.013. Epub 2011 Apr 1.

19.

The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigms.

Pandey KN.

FEBS J. 2011 Jun;278(11):1792-807. doi: 10.1111/j.1742-4658.2011.08081.x. Epub 2011 Apr 7. Review.

20.

Venom gland transcriptomes of two elapid snakes (Bungarus multicinctus and Naja atra) and evolution of toxin genes.

Jiang Y, Li Y, Lee W, Xu X, Zhang Y, Zhao R, Zhang Y, Wang W.

BMC Genomics. 2011 Jan 3;12:1. doi: 10.1186/1471-2164-12-1.

Supplemental Content

Support Center